Aptensio XR
Total Payments
$2.6M
Transactions
8,941
Doctors
3,290
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $116,999 | 2,013 | 983 |
| 2018 | $570,640 | 2,682 | 1,236 |
| 2017 | $1.9M | 4,246 | 2,350 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $2.3M | 338 | 88.4% |
| Food and Beverage | $135,338 | 8,400 | 5.3% |
| Honoraria | $117,533 | 57 | 4.6% |
| Travel and Lodging | $42,767 | 146 | 1.7% |
Payments by Type
Research
$2.3M
338 transactions
General
$295,638
8,603 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| RP-BP-EF003 | Rhodes Pharmaceuticals L.P. | $1.4M | 11 |
| RP-BP-EF004 | Rhodes Pharmaceuticals L.P. | $686,767 | 12 |
| A 12-Month Open Label Safety Study of Methylphenidate Hydrochloride Extended-Release Capsules Aptensio XR in Children Ages 4-5 Years Diagnosed with Attention-DeficitHyperactivity Disorder ADHD | Rhodes Pharmaceuticals L.P. | $86,959 | 0 |
| RP-BP-PK003 | Rhodes Pharmaceuticals L.P. | $44,147 | 1 |
| EF-003 | Rhodes Pharmaceuticals L.P. | $16,704 | 1 |
Top Doctors Receiving Payments for Aptensio XR
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Child & Adolescent Psychiatry | Memphis, TN | $643,335 | 34 |
| , M.D | Child & Adolescent Psychiatry | Dothan, AL | $302,716 | 37 |
| , MD | Family Medicine | Evansville, IN | $281,105 | 25 |
| Ann Childress | Child & Adolescent Psychiatry | Las Vegas, NV | $160,625 | 49 |
| , MD | Psychiatry | Libertyville, IL | $154,588 | 33 |
| , M.D | Psychiatry | Petersburg, VA | $145,595 | 32 |
| , MD | Pediatrics | Clinton, UT | $140,441 | 31 |
| , MD | Child & Adolescent Psychiatry | Bradenton, FL | $129,511 | 26 |
| , MD | Psychiatry | Miami, FL | $96,091 | 20 |
| Unknown | — | Clinton, UT | $86,959 | 20 |
| , MD | Emergency Medicine | Evansville, IN | $62,131 | 6 |
| Corey Hebert | Pediatrics | Gretna, LA | $50,616 | 86 |
| , MD | Psychiatry | Bellevue, WA | $43,910 | 26 |
| , M.D | Child & Adolescent Psychiatry | Troy, MI | $34,693 | 63 |
| , MD | Neurodevelopmental Disabilities | Winter Park, FL | $18,994 | 26 |
| , MD | Psychiatry | Rochester Hills, MI | $17,579 | 25 |
| , M.D | Psychiatry | Northbrook, IL | $16,898 | 33 |
| , M.D | Family Medicine | Evansville, IN | $9,227 | 4 |
| , MD | Pediatrics | Detroit, MI | $6,300 | 10 |
| , M.D | Neurology | Willoughby, OH | $5,485 | 14 |
| , M.D | Psychiatry | Houston, TX | $5,188 | 45 |
| , MD | Child & Adolescent Psychiatry | Houston, TX | $3,327 | 10 |
| Derek Ott | — | Beverly Hills, CA | $3,311 | 8 |
| , M.D | Child & Adolescent Psychiatry | Houston, TX | $2,605 | 3 |
| , MD | Psychiatry | Metuchen, NJ | $739.98 | 59 |
Ad
Manufacturing Companies
Product Information
- Type Drug
- Total Payments $2.6M
- Total Doctors 3,290
- Transactions 8,941
About Aptensio XR
Aptensio XR is a drug associated with $2.6M in payments to 3,290 healthcare providers, recorded across 8,941 transactions in the CMS Open Payments database. The primary manufacturer is Rhodes Pharmaceuticals L.P..
Payment data is available from 2017 to 2019. In 2019, $116,999 was paid across 2,013 transactions to 983 doctors.
The most common payment nature for Aptensio XR is "Unspecified" ($2.3M, 88.4% of total).
Aptensio XR is associated with 5 research studies, including "RP-BP-EF003" ($1.4M).